DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $249,588 | +17.0% | 1,006 | +13.2% | 0.03% | +21.7% |
| Q2 2023 | $213,360 | -19.1% | 889 | -15.1% | 0.02% | -20.7% |
| Q1 2023 | $263,885 | -7.4% | 1,047 | -2.5% | 0.03% | -9.4% |
| Q4 2022 | $285,061 | +28.4% | 1,074 | +41.3% | 0.03% | +33.3% |
| Q1 2022 | $222,000 | -11.2% | 760 | 0.0% | 0.02% | -11.1% |
| Q4 2021 | $250,000 | -46.4% | 760 | -24.0% | 0.03% | -6.9% |
| Q3 2021 | $466,000 | +120.9% | 1,000 | +27.1% | 0.03% | +7.4% |
| Q2 2021 | $211,000 | -21.9% | 787 | -34.6% | 0.03% | -30.8% |
| Q1 2021 | $270,000 | -8.2% | 1,204 | -9.2% | 0.04% | -13.3% |
| Q4 2020 | $294,000 | -3.6% | 1,326 | -6.4% | 0.04% | -11.8% |
| Q3 2020 | $305,000 | -1.9% | 1,417 | -19.5% | 0.05% | -8.9% |
| Q2 2020 | $311,000 | +21.0% | 1,760 | -5.5% | 0.06% | +9.8% |
| Q1 2020 | $257,000 | -14.3% | 1,863 | -4.7% | 0.05% | +2.0% |
| Q4 2019 | $300,000 | -9.4% | 1,955 | -14.8% | 0.05% | -19.4% |
| Q3 2019 | $331,000 | -7.8% | 2,294 | -8.8% | 0.06% | -1.6% |
| Q2 2019 | $359,000 | -17.3% | 2,514 | -23.7% | 0.06% | -22.2% |
| Q1 2019 | $434,000 | -7.5% | 3,294 | -27.6% | 0.08% | -18.2% |
| Q4 2018 | $469,000 | +0.4% | 4,552 | +5.7% | 0.10% | +19.3% |
| Q3 2018 | $467,000 | -2.5% | 4,305 | -11.3% | 0.08% | -7.8% |
| Q2 2018 | $479,000 | -25.5% | 4,855 | -26.0% | 0.09% | -40.0% |
| Q1 2018 | $643,000 | -52.9% | 6,565 | -55.4% | 0.15% | -42.7% |
| Q4 2017 | $1,366,000 | +6.4% | 14,722 | -1.7% | 0.26% | -1.1% |
| Q3 2017 | $1,284,000 | +8.8% | 14,971 | +7.0% | 0.26% | +3.9% |
| Q2 2017 | $1,180,000 | +1.4% | 13,988 | +2.8% | 0.26% | -9.3% |
| Q1 2017 | $1,164,000 | +15.0% | 13,611 | +4.7% | 0.28% | -4.4% |
| Q4 2016 | $1,012,000 | +6.4% | 13,002 | +7.1% | 0.29% | -7.3% |
| Q3 2016 | $951,000 | -10.9% | 12,137 | +14.9% | 0.32% | -21.9% |
| Q2 2016 | $1,067,000 | +26.3% | 10,566 | +18.6% | 0.41% | +10.0% |
| Q1 2016 | $845,000 | +15.3% | 8,906 | +12.8% | 0.37% | +4.2% |
| Q4 2015 | $733,000 | +20.0% | 7,896 | +10.0% | 0.35% | +2.3% |
| Q3 2015 | $611,000 | +16.8% | 7,176 | +17.3% | 0.35% | +18.5% |
| Q2 2015 | $523,000 | +56.1% | 6,116 | +55.2% | 0.29% | +46.7% |
| Q1 2015 | $335,000 | +35.6% | 3,941 | +37.0% | 0.20% | +29.2% |
| Q4 2014 | $247,000 | – | 2,876 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 232,593 | $60,115,000 | 16.52% |
| Defender Capital, LLC. | 139,231 | $35,988,000 | 14.10% |
| Third Point | 2,700,000 | $697,383,000 | 12.60% |
| Riverstone Advisors, LLC | 62,416 | $16,121,000 | 10.38% |
| Eos Focused Equity Management, L.P. | 32,304 | $8,344,000 | 9.87% |
| Alphinity Investment Management Pty Ltd | 1,185,235 | $306,134,000 | 9.81% |
| AGF Investments America Inc. | 88,205 | $22,782,000 | 8.41% |
| Front Street Capital Management, Inc. | 117,802 | $30,427,000 | 7.70% |
| CORTLAND ASSOCIATES INC/MO | 164,142 | $42,396,000 | 7.55% |
| THAMES CAPITAL MANAGEMENT LLC | 57,156 | $14,763,000 | 7.33% |